Sphera Funds Management’s Skye Bioscience SKYE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.25M | Sell |
538,434
-937,919
| -64% | -$3.92M | 0.53% | 56 |
|
|
2025
Q1 | $2.35M | Sell |
1,476,353
-88,275
| -6% | -$140K | 0.54% | 55 |
|
|
2024
Q4 | $4.43M | Buy |
1,564,628
+1,106
| +0.1% | +$3.13K | 0.8% | 44 |
|
|
2024
Q3 | $6.11M | Buy |
1,563,522
+265,210
| +20% | +$1.04M | 0.97% | 37 |
|
|
2024
Q2 | $10.4M | Buy |
+1,298,312
| New | +$10.4M | 1.42% | 20 |
|